IL316510A - Anti-B7H3 antibody and its uses - Google Patents

Anti-B7H3 antibody and its uses

Info

Publication number
IL316510A
IL316510A IL316510A IL31651024A IL316510A IL 316510 A IL316510 A IL 316510A IL 316510 A IL316510 A IL 316510A IL 31651024 A IL31651024 A IL 31651024A IL 316510 A IL316510 A IL 316510A
Authority
IL
Israel
Prior art keywords
antibody
Prior art date
Application number
IL316510A
Other languages
English (en)
Hebrew (he)
Inventor
Naiyan Rong
Zhuozhi Wang
Jie Li
Jijie Gu
Original Assignee
Wuxi Biologics Ireland Ltd
Naiyan Rong
Zhuozhi Wang
Jie Li
Jijie Gu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi Biologics Ireland Ltd, Naiyan Rong, Zhuozhi Wang, Jie Li, Jijie Gu filed Critical Wuxi Biologics Ireland Ltd
Publication of IL316510A publication Critical patent/IL316510A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL316510A 2022-05-18 2023-05-17 Anti-B7H3 antibody and its uses IL316510A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2022093524 2022-05-18
PCT/CN2023/094711 WO2023222017A1 (en) 2022-05-18 2023-05-17 Anti-b7h3 antibody and uses thereof

Publications (1)

Publication Number Publication Date
IL316510A true IL316510A (en) 2024-12-01

Family

ID=88834684

Family Applications (1)

Application Number Title Priority Date Filing Date
IL316510A IL316510A (en) 2022-05-18 2023-05-17 Anti-B7H3 antibody and its uses

Country Status (12)

Country Link
US (1) US20250313633A1 (enExample)
EP (1) EP4526346A1 (enExample)
JP (1) JP2025517737A (enExample)
KR (1) KR20250011957A (enExample)
CN (1) CN119256010A (enExample)
AU (1) AU2023273853A1 (enExample)
CA (1) CA3253563A1 (enExample)
CL (1) CL2024003486A1 (enExample)
IL (1) IL316510A (enExample)
MX (1) MX2024014232A (enExample)
TW (1) TW202402808A (enExample)
WO (1) WO2023222017A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118829656B (zh) * 2023-12-01 2026-04-24 苏州智核生物医药科技有限公司 B7h3结合多肽及其用途
WO2025157244A1 (zh) * 2024-01-25 2025-07-31 山东先声生物制药有限公司 抗b7h3抗体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012501751A1 (en) * 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
AU2015306621B2 (en) * 2014-08-27 2021-05-06 Memorial Sloan Kettering Cancer Center Antibodies, compositions, and uses
UA125593C2 (uk) * 2017-03-31 2022-04-27 Джянгсу Хенгруй Медісін Ко., Лтд. Антитіло в7-н3, його антигензв'язуючий фрагмент та його медичне застосування
KR102732027B1 (ko) * 2019-07-09 2024-11-20 주식회사 와이바이오로직스 B7-h3(cd276)에 특이적으로 결합하는 항체 및 그의 용도
CN112851812B (zh) * 2020-06-30 2021-09-14 广州百暨基因科技有限公司 抗b7h3抗体及其应用
CN113402610B (zh) * 2021-06-09 2023-02-24 英诺湖医药(杭州)有限公司 一组b7h3单克隆抗体及其医药用途
CN113336851B (zh) * 2021-06-30 2021-12-24 徐州医科大学 新型全人源抗人b7h3抗体、包含所述抗体的组合物及其应用

Also Published As

Publication number Publication date
CA3253563A1 (en) 2023-11-23
CL2024003486A1 (es) 2025-06-13
WO2023222017A1 (en) 2023-11-23
US20250313633A1 (en) 2025-10-09
CN119256010A (zh) 2025-01-03
JP2025517737A (ja) 2025-06-10
TW202402808A (zh) 2024-01-16
MX2024014232A (es) 2025-03-07
AU2023273853A1 (en) 2024-10-24
EP4526346A1 (en) 2025-03-26
KR20250011957A (ko) 2025-01-22

Similar Documents

Publication Publication Date Title
IL308808A (en) Antibodies against CCR8 and their uses
GB2610467B (en) Anti-CLL1 antibody and application thereof
IL319931A (en) Anti-CD122 antibodies and their uses
GB202017058D0 (en) Antibodies and uses thereof
IL307267A (en) ANTI-CD122 antibodies and their uses
IL310662A (en) Anti-CD161 antibodies and their uses
IL307940A (en) Anti-ADGRE2 antibodies and their uses
IL320586A (en) Anti-trem2 antibody and its uses
IL327202A (en) Anti-CDH17 antibodies and their uses
EP4464722A4 (en) ANTIBODIES AND THEIR USE
HRP20260098T1 (hr) Anti-gprc5d monoklonska protutijela i njihova upotreba
EP4169950A4 (en) ANTI-LILRB1 ANTIBODIES AND ITS USES
IL317391A (en) Novel anti-LILRB4 antibodies and their uses
IL307939A (en) Anti-CLEC12A antibodies and uses thereof
IL319145A (en) Novel anti-LILRB2 antibodies and their uses
EP4490199A4 (en) MODIFIED ANTIBODIES AND THEIR USES
EP4437000A4 (en) ANTI-TREM2 ANTIBODY AND ITS USES
IL304412A (en) Antibodies against cd112r and uses thereof
IL312584A (en) ANTI-VISTA antibodies and their uses
IL320972A (en) Anti-TFR1 antibodies and their uses
IL310028A (en) Antibody and its use
IL310810A (en) Anti-ACVR2A antibodies and uses thereof
IL307233A (en) Anti-SEMA3A antibodies and uses thereof
GB202303531D0 (en) Antibodies and uses thereof
IL308198A (en) Anti-IL-27 antibodies and uses thereof